Odessa Native and Aperiomics CEO Dr. Crystal Icenhour at TEDxOptimistPark: Why Infectious Diseases Don’t Stand a Chance Against New DNA Analysis

Presentation February 24 at UTPB J. Conrad Dunagan Library

Odessa, TX, February 15, 2017 – Dr. Crystal Icenhour, born in Odessa, TX, is changing the way the medical industry thinks about fighing chronic infectious diseases with new methods of DNA analysis and will be a featured speaker Saturday, Febuary 24 at TEDxOptimistPark in Odessa.

The event takes place Saturday, February 24, at UTPB J. Conrad Dunagan Library from 9:30 a.m.-2:30 p.m. https://www.ted.com/tedx/events/26419

Icenhour is CEO of Aperiomics, located just outside of Washington, D.C. She leads a team that has developed proprietary technology that has revolutionized the scope and accuracy of infectious disease testing using deep DNA analysis. Today, up to 75% of infections are never actually diagnosed, wasting time and millions of dollars spent in trial-and-error testing. Aperiomics has helped doctors worldwide detect the cause of their patients’ infections, some lasting decades, giving them information helpful in developing effective treatment strategies.

Icenhour holds two patents. She is a prolific speaker and writer on biotechnology and infectious diseases and has served on review panels for the NSF, the EPA and NIH. She is an adjunct professor of medicine at Duke University Medical Center. Icenhour received her PhD in pathobiology and molecular medicine, trained as a postdoctoral fellow in thoracic diseases at the Mayo Clinic, as well as at Duke University Medical Center.

About Aperiomics

Aperiomics is the only company identifying every bacteria, DNA virus, fungi and parasite in one test. Clinicians and patients call on Aperiomics to identify infectious diseases that other tests cannot identify. The only company of its kind and scope in the world, Aperiomics identifies every known pathogen (bacteria, virus, fungi or parasite) in a single test through deep shotgun metagenomic sequencing of the DNA in any sample (patient, environmental, etc.). The complete genetic fingerprint of that sample is then compared to the Aperiomics Microbial Database™- the most comprehensive database of microorganisms, including the world’s largest collection of pathogens. This breakthrough is only possible through Aperiomics and can be used to identify unknown/chronic infections, limit the use of antibiotics and solve difficult medical cases. Patients and their families often contact Aperiomics directly after hearing about our successes in helping others. Aperiomics is supported by the National Science Foundation and was named Life Sciences Innovators of the Year in 2016 and a finalist in the 2017 Greater Washington Innovation Awards. For more information, visit www.aperiomics.com or call (703) 229-0406.